Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form

The present study describes a simple, accurate, precise and cost effective UV-Vis Spectroscopic and RP-HPLC method for the estimation of Ibandronate sodium (IBN). The determination of Ibandronate sodium (IBN) was performed by both UV and RP-HPLC method using 215 nm as the determination wavelength. T...

Full description

Bibliographic Details
Main Authors: Priyanka Bose, Suddhasattya Dey, Souvik Basak, Shreya Shah, Anjan De
Format: Article
Language:English
Published: Iranian Chemical Society 2015-12-01
Series:Analytical and Bioanalytical Chemistry Research
Subjects:
Online Access:http://www.analchemres.org/article_10758_6e7865b53685ad91f446371261f18ae7.pdf
_version_ 1831756291623616512
author Priyanka Bose
Suddhasattya Dey
Souvik Basak
Shreya Shah
Anjan De
author_facet Priyanka Bose
Suddhasattya Dey
Souvik Basak
Shreya Shah
Anjan De
author_sort Priyanka Bose
collection DOAJ
description The present study describes a simple, accurate, precise and cost effective UV-Vis Spectroscopic and RP-HPLC method for the estimation of Ibandronate sodium (IBN). The determination of Ibandronate sodium (IBN) was performed by both UV and RP-HPLC method using 215 nm as the determination wavelength. The drug was dissolved in NaOH solution (0.1N NaOH) for estimation in UV and in distilled water for the estimation in RP-HPLC using mobile phase 0.01 M Sodium dihydrogen phosphate (NaH2PO4): Acetonitrile (80:20), pH being adjusted to 3.3 with 10% ortho-phosphoric acid. A linear response was observed in the range of 10-50 μg ml-1 (R2 = 0.9981) for UV-Spectroscopy, whereas for RP-HPLC the linear response was observed in the range of 20-70 μg ml-1 (R2 = 0.9965). The limits of quantitation (LOQ) were estimated as 0.1 μg ml-1 and 0.05 μg ml-1, respectively for UV and RP-HPLC respectively. The recoveries of IBN from the marketed formulation were found to be within 100 ± 2% by both the methods. These methods were then effectively applied for the estimation of Boniva (tablet) and the results were obtained according to nominal content. The statistical analysis revealed that there is no significant difference (p > 0.05) between UV and HPLC methods regarding validation parameters and assay content.
first_indexed 2024-12-22T00:10:08Z
format Article
id doaj.art-a3d3304abc9b439bb6c69a30d156305b
institution Directory Open Access Journal
issn 2383-093X
2383-093X
language English
last_indexed 2024-12-22T00:10:08Z
publishDate 2015-12-01
publisher Iranian Chemical Society
record_format Article
series Analytical and Bioanalytical Chemistry Research
spelling doaj.art-a3d3304abc9b439bb6c69a30d156305b2022-12-21T18:45:27ZengIranian Chemical SocietyAnalytical and Bioanalytical Chemistry Research2383-093X2383-093X2015-12-01229911210.22036/abcr.2015.1075810758Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage FormPriyanka Bose0Suddhasattya Dey1Souvik Basak2Shreya Shah3Anjan De4Dr. B.C. Roy College of Pharmacy & AHSWBUTWBUTSigma Institute of PharmacyWBUTThe present study describes a simple, accurate, precise and cost effective UV-Vis Spectroscopic and RP-HPLC method for the estimation of Ibandronate sodium (IBN). The determination of Ibandronate sodium (IBN) was performed by both UV and RP-HPLC method using 215 nm as the determination wavelength. The drug was dissolved in NaOH solution (0.1N NaOH) for estimation in UV and in distilled water for the estimation in RP-HPLC using mobile phase 0.01 M Sodium dihydrogen phosphate (NaH2PO4): Acetonitrile (80:20), pH being adjusted to 3.3 with 10% ortho-phosphoric acid. A linear response was observed in the range of 10-50 μg ml-1 (R2 = 0.9981) for UV-Spectroscopy, whereas for RP-HPLC the linear response was observed in the range of 20-70 μg ml-1 (R2 = 0.9965). The limits of quantitation (LOQ) were estimated as 0.1 μg ml-1 and 0.05 μg ml-1, respectively for UV and RP-HPLC respectively. The recoveries of IBN from the marketed formulation were found to be within 100 ± 2% by both the methods. These methods were then effectively applied for the estimation of Boniva (tablet) and the results were obtained according to nominal content. The statistical analysis revealed that there is no significant difference (p > 0.05) between UV and HPLC methods regarding validation parameters and assay content.http://www.analchemres.org/article_10758_6e7865b53685ad91f446371261f18ae7.pdfIbandronate sodium (IBN)UV-vis spectroscopyRP-HPLCCalibration curveLOD
spellingShingle Priyanka Bose
Suddhasattya Dey
Souvik Basak
Shreya Shah
Anjan De
Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
Analytical and Bioanalytical Chemistry Research
Ibandronate sodium (IBN)
UV-vis spectroscopy
RP-HPLC
Calibration curve
LOD
title Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
title_full Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
title_fullStr Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
title_full_unstemmed Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
title_short Simultaneous RP-HPLC and UV Spectroscopic Method Development and Validation for Estimation of Ibandronate Sodium in Bulk and Pharmaceutical Dosage Form
title_sort simultaneous rp hplc and uv spectroscopic method development and validation for estimation of ibandronate sodium in bulk and pharmaceutical dosage form
topic Ibandronate sodium (IBN)
UV-vis spectroscopy
RP-HPLC
Calibration curve
LOD
url http://www.analchemres.org/article_10758_6e7865b53685ad91f446371261f18ae7.pdf
work_keys_str_mv AT priyankabose simultaneousrphplcanduvspectroscopicmethoddevelopmentandvalidationforestimationofibandronatesodiuminbulkandpharmaceuticaldosageform
AT suddhasattyadey simultaneousrphplcanduvspectroscopicmethoddevelopmentandvalidationforestimationofibandronatesodiuminbulkandpharmaceuticaldosageform
AT souvikbasak simultaneousrphplcanduvspectroscopicmethoddevelopmentandvalidationforestimationofibandronatesodiuminbulkandpharmaceuticaldosageform
AT shreyashah simultaneousrphplcanduvspectroscopicmethoddevelopmentandvalidationforestimationofibandronatesodiuminbulkandpharmaceuticaldosageform
AT anjande simultaneousrphplcanduvspectroscopicmethoddevelopmentandvalidationforestimationofibandronatesodiuminbulkandpharmaceuticaldosageform